Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Combating Neurodegenerative Diseases with the Plant Alkaloid Berberine: Molecular Mechanisms and Therapeutic Potential
Dahua Fan, Liping Liu, Zhengzhi Wu, et al.
Current Neuropharmacology (2018) Vol. 17, Iss. 6, pp. 563-579
Open Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

Phytobioactive compounds as therapeutic agents for human diseases: A review
Muhammad Riaz, Ramsha Khalid, Muhammad Afzal, et al.
Food Science & Nutrition (2023) Vol. 11, Iss. 6, pp. 2500-2529
Open Access | Times Cited: 106
Berberine ameliorates depression-like behaviors in mice via inhibiting NLRP3 inflammasome-mediated neuroinflammation and preventing neuroplasticity disruption
Zongshi Qin, Dongdong Shi, Wenqi Li, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 61
Berberine ameliorates iron levels and ferroptosis in the brain of 3 × Tg-AD mice
Xinlu Li, Jianfeng Chen, Wennuo Feng, et al.
Phytomedicine (2023) Vol. 118, pp. 154962-154962
Closed Access | Times Cited: 47
The chemistry of heterocycles in the 21st century
Valery N. Charushin, Egor V. Verbitskiy, О. Н. Чупахин, et al.
Russian Chemical Reviews (2024) Vol. 93, Iss. 7, pp. RCR5125-RCR5125
Closed Access | Times Cited: 28
Berberine: A Promising Treatment for Neurodegenerative Diseases
Ziqian Cheng, Chenglan Kang, Songtian Che, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 47
Neuroprotective Properties of Berberine: Molecular Mechanisms and Clinical Implications
Erjie Tian, Gaurav Sharma, Chongshan Dai
Antioxidants (2023) Vol. 12, Iss. 10, pp. 1883-1883
Open Access | Times Cited: 33
Berberine inhibits RA-FLS cell proliferation and adhesion by regulating RAS/MAPK/FOXO/HIF-1 signal pathway in the treatment of rheumatoid arthritis
Zhiqi Li, Meilin Chen, Zhaoyi Wang, et al.
Bone and Joint Research (2023) Vol. 12, Iss. 2, pp. 91-102
Open Access | Times Cited: 30
Potential therapeutic use of plant flavonoids in AD and PD
Sun Meng-zhen, Li Ju, Lanchun Zhang, et al.
Heliyon (2022) Vol. 8, Iss. 11, pp. e11440-e11440
Open Access | Times Cited: 31
Berberine alleviates rotenone-induced cytotoxicity by antioxidation and activation of PI3K/Akt signaling pathway in SH-SY5Y cells
Han Deng, Yi Jia, Dong Pan, et al.
Neuroreport (2019) Vol. 31, Iss. 1, pp. 41-47
Closed Access | Times Cited: 45
Berberine Suppresses Stemness and Tumorigenicity of Colorectal Cancer Stem-Like Cells by Inhibiting m6A Methylation
Ziyi Zhao, Jinhao Zeng, Qiang Guo, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 40
Polyphenolic molecules targeting STAT3 pathway for the treatment of cancer
Md. Abdul Aziz, Md Shahid Sarwar, Tahmina Akter, et al.
Life Sciences (2021) Vol. 268, pp. 118999-118999
Closed Access | Times Cited: 35
Neuroprotective effect and preparation methods of berberine
Yi-Xuan Sunhe, Yuehui Zhang, Rui‐Jia Fu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
Key epigenetic enzymes modulated by natural compounds contributes to tumorigenicity
Xiaoyue Zhou, Wanqing Liu, Ziqi Liang, et al.
International Journal of Biological Macromolecules (2025), pp. 140391-140391
Closed Access
Network pharmacology study on the mechanism of berberine in Alzheimer’s disease model
Yu‐Zhong Zhang, Shuai Lv, Pei-Zheng Huang, et al.
npj Science of Food (2025) Vol. 9, Iss. 1
Open Access
Neuroprotective efficacy of berberine and caffeine against rotenone‐induced neuroinflammatory and oxidative disturbances associated with Parkinson’s disease via inhibiting α-synuclein aggregation and boosting dopamine release
Tasnim S. Waheeb, Mohammad A. Abdulkader, Doaa A. Ghareeb, et al.
Inflammopharmacology (2025)
Open Access
Network pharmacology-based strategy to investigate pharmacological mechanisms of Tinospora sinensis for treatment of Alzheimer's disease
Feng Zhou, Kunlun He, Guan Yang, et al.
Journal of Ethnopharmacology (2020) Vol. 259, pp. 112940-112940
Closed Access | Times Cited: 36
Treatment of Parkinson's disease in Zebrafish model with a berberine derivative capable of crossing blood brain barrier, targeting mitochondria, and convenient for bioimaging experiments
Lizhen Wang, Wenlong Sheng, Zhaoshun Tan, et al.
Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology (2021) Vol. 249, pp. 109151-109151
Closed Access | Times Cited: 27
Integrated Analysis of m6A Methylome in Cisplatin-Induced Acute Kidney Injury and Berberine Alleviation in Mouse
Jianxiao Shen, Wanpeng Wang, Xinghua Shao, et al.
Frontiers in Genetics (2020) Vol. 11
Open Access | Times Cited: 29
Bitter yet beneficial: The dual role of dietary alkaloids in managing diabetes and enhancing cognitive function
Majed Abdo Alkanad, Umme Hani, H. V. Annegowda, et al.
BioFactors (2024) Vol. 50, Iss. 4, pp. 634-673
Closed Access | Times Cited: 3
Prepubertal Repeated Berberine Supplementation Enhances Cerebrocerebellar Functions by Modulating Neurochemical and Behavioural Changes in Wistar Rats
Solomon E. Owumi, Joseph Chimezie, Moses T. Otunla, et al.
Journal of Molecular Neuroscience (2024) Vol. 74, Iss. 3
Closed Access | Times Cited: 3
Ameliorating Ribosylation-Induced Amyloid-β Pathology by Berberine via Inhibiting mTOR/p70S6K Signaling
Yangyang Wang, Qian Yan, Zhenting Huang, et al.
Journal of Alzheimer s Disease (2020) Vol. 79, Iss. 2, pp. 833-844
Closed Access | Times Cited: 26
Neuroprotective Effect for Cerebral Ischemia by Natural Products: A Review
Qian Xie, Hongyan Li, Danni Lu, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 22
Recent Progress on Biological Activity of Amaryllidaceae and Further Isoquinoline Alkaloids in Connection with Alzheimer’s Disease
Lucie Cahlíková, Rudolf Vrabec, Filip Pidaný, et al.
Molecules (2021) Vol. 26, Iss. 17, pp. 5240-5240
Open Access | Times Cited: 22
Paradigms and Success Stories of Natural Products in Drug Discovery Against Neurodegenerative Disorders (NDDs)
Sukhwinder Singh, Shivani Chib, Md Jawaid Akhtar, et al.
Current Neuropharmacology (2023) Vol. 22, Iss. 6, pp. 992-1015
Open Access | Times Cited: 8
Berberine Alleviates the Damage, Oxidative Stress and Mitochondrial Dysfunction of PC12 Cells Induced by High Glucose by Activating the KEAP1/Nrf2/ARE Pathway
Haoyu Yuan, Baohua Wang, Zicheng Ye, et al.
Molecular Biotechnology (2023) Vol. 65, Iss. 10, pp. 1632-1643
Closed Access | Times Cited: 8
Page 1 - Next Page

Scroll to top